Orthovita Cortoss
This article was originally published in The Gray Sheet
Executive Summary
Synthetic cortical bone void filler receives CE mark for vertebral augmentation, including compression fractures caused by osteoporosis and invasive tumors. Patient enrollment for a 20-patient, U.S. pilot trial assessing Cortoss for vertebral augmentation began early this year. Advantages over PMMA bone cement include improved visualization and reduced risk of thermal tissue damage (1"The Gray Sheet" Aug. 26, 2002, p. 28)...